tiprankstipranks
Trending News
More News >

Shanghai Pharmaceuticals Announces 2025 AGM with Key Proposals

Story Highlights
Shanghai Pharmaceuticals Announces 2025 AGM with Key Proposals

Don’t Miss TipRanks’ Half-Year Sale

An update from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) is now available.

Shanghai Pharmaceuticals Holding Co., Ltd. has announced its Annual General Meeting scheduled for June 26, 2025, where several key proposals will be considered. These include the approval of the 2024 Annual Report, financial plans for 2025, profit distribution, re-appointment of the accounting firm, and issuance of corporate bonds, which could significantly impact the company’s financial strategy and stakeholder interests.

The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.

More about Shanghai Pharmaceuticals Holding Co

Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company based in the People’s Republic of China, primarily engaged in the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products and services, catering to a wide market within the healthcare sector.

Average Trading Volume: 5,337,783

Technical Sentiment Signal: Sell

Current Market Cap: HK$65.5B

Learn more about 2607 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1